Related Experiment Video
Updated: Jun 12, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Growth factor stimulation induces cell survival by c-Jun. ATF2-dependent activation of Bcl-XL
Ahmad Salameh1, Federico Galvagni, Francesca Anselmi
1Dipartimento di Biologia Molecolare, Universita' di Siena, 53100 Siena, Italy.
Abstract:
Growth factor stimulation induces c-Jun-dependent survival of primary endothelial cells. However, the mechanism of c-Jun anti-apoptotic activity has not been identified. We here demonstrate that in response to growth factor treatment, primary human endothelial cells as well as mouse fibroblasts respond with an increased expression of c-Jun that forms a complex with ATF2. This complex activates the expression of the anti-apoptotic protein Bcl-X(L). By site-directed mutagenesis experiments, we identified two AP-1-binding sites located within the proximal promoter of the Bcl-X gene. Site-directed mutagenesis demonstrated that these AP-1 sites are required for the transcriptional activation of the promoter. Chromatin immunoprecipitation experiments show that in response to growth factor treatment, the heterodimer c-Jun.ATF2 binds to these functional AP-1 sites. Silencing of either c-Jun or ATF2 demonstrated that both nuclear factors are required for the activation of the proximal Bcl-X promoter. Taken together, our experiments provide evidence that growth factor-independent signaling pathways converge in the formation of an active c-Jun.AFT2 dimer, which induces the expression of the anti-apoptotic factor Bcl-X(L) that mediates a pro-survival response.
Insights
Growth factors promote cell survival by increasing c-Jun expression, which binds ATF2 to activate the anti-apoptotic Bcl-X(L) protein. This c-Jun.ATF2 dimer mechanism explains cell survival pathways.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Growth factor stimulation promotes endothelial cell survival via c-Jun.
- The precise mechanism of c-Jun's anti-apoptotic function remains unclear.
Purpose of the Study:
- To elucidate the mechanism by which c-Jun mediates anti-apoptotic activity.
- To identify the downstream targets and signaling pathways involved in growth factor-induced cell survival.
Main Methods:
- Quantitative real-time PCR to measure gene expression.
- Western blotting to detect protein levels and complex formation.
- Site-directed mutagenesis to analyze promoter activity.
- Chromatin immunoprecipitation (ChIP) to assess protein-DNA binding.
- siRNA-mediated gene silencing to knock down c-Jun and ATF2.
Main Results:
- Growth factor treatment increased c-Jun expression, forming a complex with ATF2.
- The c-Jun.ATF2 complex was found to activate the expression of the anti-apoptotic protein Bcl-X(L).
- Two AP-1 binding sites in the Bcl-X promoter were identified as crucial for transcriptional activation by c-Jun.ATF2.
- ChIP assays confirmed that the c-Jun.ATF2 dimer binds to these sites upon growth factor stimulation.
- Silencing of c-Jun or ATF2 abolished the activation of the Bcl-X promoter.
Conclusions:
- Growth factor signaling converges on the formation of an active c-Jun.ATF2 dimer.
- This dimer induces Bcl-X(L) expression, mediating a pro-survival response in endothelial cells and fibroblasts.
- The study reveals a novel mechanism for c-Jun-dependent cell survival involving Bcl-X(L) regulation.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Mitogens and the Cell Cycle
TGF - β Signaling Pathway
The Extrinsic Apoptotic Pathway
Cells Coordinate Growth and Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

